{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:23:09Z","timestamp":1791559389648,"version":"4.3.4"},"reference-count":201,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP230204"],"award-info":[{"award-number":["RP230204"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210213"],"award-info":[{"award-number":["RP210213"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101077312"],"award-info":[{"award-number":["101077312"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajpath.2024.07.009","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:22:40Z","timestamp":1722972160000},"page":"378-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-3913","authenticated-orcid":false,"given":"Silvia","family":"Aff\u1f78","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4025-0288","authenticated-orcid":false,"given":"Laura","family":"Sererols-Vi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6428-1847","authenticated-orcid":false,"given":"Gemma","family":"Garcia-Vici\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Cadamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjukta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-3829","authenticated-orcid":false,"given":"Alphonse E.","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2024.07.009_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2024.07.009_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2020.10.005","article-title":"Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression","volume":"149","author":"Sirica","year":"2021","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","article-title":"Pathology of intrahepatic cholangiocarcinoma","volume":"6","author":"Vijgen","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.ajpath.2024.07.009_bib4","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/hep.26762","article-title":"Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting","volume":"59","author":"Sirica","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.07.009_bib6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.30289","article-title":"Intrahepatic cholangiocarcinoma: continuing challenges and translational advances","volume":"69","author":"Sirica","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Aff\u00f2","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrgastro.2011.222","article-title":"The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma","volume":"9","author":"Sirica","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00000478-199908000-00006","article-title":"The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth","volume":"23","author":"Kajiyama","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib11","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1158\/2159-8290.CD-12-0348","article-title":"Desmoplasia: a response or a niche?","volume":"2","author":"DeClerck","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.07.009_bib13","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib14","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.21873\/anticanres.14476","article-title":"Prognostic impact of desmoplastic reaction evaluation for intrahepatic cholangiocarcinoma","volume":"40","author":"Kojima","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41379-020-00656-y","article-title":"Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma","volume":"34","author":"Guedj","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"Mertens","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib17","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1172\/JCI136760","article-title":"Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix","volume":"130","author":"Jiang","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.07.009_bib18","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.3390\/jcm11216498","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma: current knowledge and possible implications for therapy","volume":"11","author":"Montori","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib20","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.07.009_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.07.009_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2014.00062","article-title":"Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment","volume":"4","author":"Augsten","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2024.07.009_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/HEP.0000000000000206","article-title":"Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma","volume":"79","author":"Cantallops Vil\u00e0","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.08.004","article-title":"Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins","volume":"62","author":"Zeltz","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.acr.2022.01.009","article-title":"Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance","volume":"156","author":"Ravichandra","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.01.006","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma","volume":"15","author":"Ying","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib30","doi-asserted-by":"crossref","first-page":"59766","DOI":"10.18632\/oncotarget.11121","article-title":"Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells","volume":"7","author":"Goncalves-Ribeiro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.07.009_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4254\/wjh.v9.i9.455","article-title":"Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness","volume":"9","author":"Brivio","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MOG.0b013e32834405c3","article-title":"Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma","volume":"27","author":"Sirica","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.22088","article-title":"A novel \"patient-like\" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines","volume":"47","author":"Sirica","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep4.1131","article-title":"Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model","volume":"2","author":"Manzanares","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2024.07.009_bib35","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.molonc.2014.04.006","article-title":"Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information","volume":"8","author":"Berdiel-Acer","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","article-title":"Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer","volume":"38","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","article-title":"Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression","volume":"11","author":"Francescone","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.07.009_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ccell.2015.11.002","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"28","author":"Ozdemir","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stanger BZ: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib41","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.07.009_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcmgh.2023.09.008","article-title":"The origin and fate of liver myofibroblasts","volume":"17","author":"Kim","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2016.07.001","article-title":"The characteristics of activated portal fibroblasts\/myofibroblasts in liver fibrosis","volume":"92","author":"Karin","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2024.07.009_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Aff\u00f2","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib49","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib51","doi-asserted-by":"crossref","first-page":"22835","DOI":"10.1074\/jbc.M114.563064","article-title":"Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis","volume":"289","author":"Rizvi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.07.009_bib52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajpath.2017.01.013","article-title":"Transforming growth factors alpha and beta are essential for modeling cholangiocarcinoma desmoplasia and progression in a three-dimensional organotypic culture model","volume":"187","author":"Manzanares","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.acr.2022.01.010","article-title":"Matricellular proteins in intrahepatic cholangiocarcinoma","volume":"156","author":"Sirica","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/cells8090960","article-title":"Transforming growth factor-beta (TGFbeta) signaling pathway in cholangiocarcinoma","volume":"8","author":"Papoutsoglou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.07.009_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/ajpath.2010.090747","article-title":"Epithelial-mesenchymal transition induced by transforming growth factor-beta1\/Snail activation aggravates invasive growth of cholangiocarcinoma","volume":"177","author":"Sato","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40659-015-0016-9","article-title":"TGF-beta1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma","volume":"48","author":"Chen","year":"2015","journal-title":"Biol Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib57","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3390\/cancers12123650","article-title":"TGF-beta mediated immune evasion in cancer-spotlight on cancer-associated fibroblasts","volume":"12","author":"Ghahremanifard","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.07.009_bib59","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.07.009_bib60","first-page":"130","article-title":"Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies","volume":"2","author":"Cadamuro","year":"2013","journal-title":"Transl Gastrointest Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib61","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.1013805107","article-title":"Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts","volume":"107","author":"Kojima","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.07.009_bib62","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.26585","article-title":"Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor","volume":"58","author":"Clap\u00e9ron","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib63","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.07.009_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.790032","article-title":"The role of mesothelin signaling in portal fibroblasts in the pathogenesis of cholestatic liver fibrosis","volume":"8","author":"Fuji","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib65","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.07.009_bib67","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.07.009_bib68","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","article-title":"Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer","volume":"12","author":"McAndrews","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.07.009_bib69","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","article-title":"Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing","volume":"9","author":"Bartoschek","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.07.009_bib70","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.7150\/thno.72853","article-title":"The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases","volume":"12","author":"Giguelay","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ajpath.2024.07.009_bib71","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","article-title":"Cancer-associated fibroblasts in colorectal cancer","volume":"24","author":"Kamali Zonouzi","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib73","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced jak\/stat signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.07.009_bib75","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.07.009_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ceb.2018.09.002","article-title":"Cancer associated fibroblasts: is the force the path to the dark side?","volume":"56","author":"Barbazan","year":"2019","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib77","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/2159-8290.CD-16-0733","article-title":"Tissue force programs cell fate and tumor aggression","volume":"7","author":"Northey","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.07.009_bib78","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2468-1253(23)00111-5","article-title":"Fibroblasts in liver cancer: functions and therapeutic translation","volume":"8","author":"Aff\u00f2","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13046-022-02484-1","article-title":"The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?","volume":"41","author":"Jurj","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9284","article-title":"Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis","volume":"11","author":"Yang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib81","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M109.027466","volume":"284","author":"Bourguignon","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.07.009_bib82","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-022-11463-x","article-title":"Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection","volume":"29","author":"Choi","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib83","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/hep.31598","article-title":"Group: on behalf of the European Network for the Study of Cholangiocarcinoma (ENS-CCA): liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system","volume":"73","author":"Lamarca","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib84","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s00261-023-03991-1","article-title":"Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size","volume":"48","author":"Kolck","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7195373","article-title":"Distant metastases in patients with intrahepatic cholangiocarcinoma: does location matter? A retrospective analysis of 370 patients","volume":"2020","author":"Hahn","year":"2020","journal-title":"J Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib86","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1245\/s10434-017-5870-y","article-title":"Impact of morphological status on long-term outcome among patients undergoing liver surgery for intrahepatic cholangiocarcinoma","volume":"24","author":"Bagante","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib87","article-title":"Peritoneal metastasis of cholangiocarcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at the Instituto Nacional de Cancerologia, Colombia","volume":"12","author":"Hernandez","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ajpath.2024.07.009_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/15396850360495673","article-title":"Lymphangioblasts in embryonic lymphangiogenesis","volume":"1","author":"Wilting","year":"2003","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib90","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3892\/mco.2017.1356","article-title":"The optimum marker for the detection of lymphatic vessels","volume":"7","author":"Kong","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib91","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009092","article-title":"VEGFR and type-V RTK activation and signaling","volume":"5","author":"Shibuya","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib92","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/jpm12071086","article-title":"Translational value of tumor-associated lymphangiogenesis in cholangiocarcinoma","volume":"12","author":"Cadamuro","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib93","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmed.2019.00293","article-title":"Inflammation and progression of cholangiocarcinoma: role of angiogenic and lymphangiogenic mechanisms","volume":"6","author":"Roy","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2013.12.001","article-title":"Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis","volume":"346","author":"Ji","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-030-12734-3_5","article-title":"Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer","volume":"1136","author":"Schito","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib96","article-title":"New insights on the role of vascular endothelial growth factor in biliary pathophysiology","volume":"3","author":"Mariotti","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib97","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/modpathol.3800985","article-title":"Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma","volume":"21","author":"Aishima","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib98","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ajg.2009.674","article-title":"Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma","volume":"105","author":"Thelen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib99","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12885-019-5420-z","article-title":"Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma","volume":"19","author":"Sha","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib100","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/ijbs.26045","article-title":"Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis","volume":"14","author":"Sha","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib101","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.coc.0000204402.29830.08","article-title":"The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma","volume":"29","author":"Park","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib102","first-page":"2705","article-title":"Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma","volume":"25","author":"Liang","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib104","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.2147\/OTT.S215276","article-title":"Receptor-interacting protein kinase 1 promotes cholangiocarcinoma proliferation and lymphangiogenesis through the activation protein 1 pathway","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ajpath.2024.07.009_bib105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2021.07.016","article-title":"Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma","volume":"75","author":"Carpino","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200903137","article-title":"Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3","volume":"188","author":"Xu","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12885-016-2259-4","article-title":"TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1\/2\/AP-1\/VEGF-D pathway","volume":"16","author":"Hong","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib108","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2147\/OTT.S159026","article-title":"RIP1 regulates TNF-alpha-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-kappaB-VEGF-C pathway","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ajpath.2024.07.009_bib109","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1038\/onc.2011.28","article-title":"Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis","volume":"30","author":"Bist","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2024.07.009_bib110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00535-023-02012-8","article-title":"Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma","volume":"58","author":"Peng","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib111","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/cells10113093","article-title":"Tumor lymphatic interactions induce CXCR2-CXCL5 axis and alter cellular metabolism and lymphangiogenic pathways to promote cholangiocarcinoma","volume":"10","author":"Roy","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.07.009_bib112","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","article-title":"Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer","volume":"71","author":"Yoo","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib113","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1878-0261.12092","article-title":"Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system","volume":"11","author":"Karlsson","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-022-00406-z","article-title":"Advances of cancer-associated fibroblasts in liver cancer","volume":"10","author":"Peng","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.14336\/AD.2023.0420","article-title":"Cancer-associated fibroblasts promote lymphatic metastasis in cholangiocarcinoma via the PDGF-BB\/PDGFR-beta mediated paracrine signaling network","volume":"15","author":"Yan","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.ajpath.2024.07.009_bib116","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.gendis.2023.02.023","article-title":"Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma","volume":"10","author":"Sha","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.ajpath.2024.07.009_bib117","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cortes-Guiral","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.07.009_bib118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-02854-5","article-title":"Tumor microenvironment in ovarian cancer peritoneal metastasis","volume":"23","author":"Mei","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ajpath.2024.07.009_bib119","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/jcm12010103","article-title":"Development of the peritoneal metastasis: a review of back-grounds, mechanisms, treatments and prospects","volume":"12","author":"Ren","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib120","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215914","article-title":"The molecular biology of peritoneal metastatic disease","volume":"15","author":"Bootsma","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib121","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10555-020-09924-4","article-title":"Molecular mediators of peritoneal metastasis in pancreatic cancer","volume":"39","author":"Avula","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ajpath.2024.07.009_bib122","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1104694","article-title":"Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity","volume":"14","author":"Miyamoto","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib124","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijc.25961","article-title":"The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer","volume":"130","author":"Yamamura","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib125","first-page":"6991","article-title":"Mechanisms of peritoneal dissemination in gastric cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib126","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","article-title":"Better together: circulating tumor cell clustering in metastatic cancer","volume":"7","author":"Schuster","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib127","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \"soil\" for a cancerous \"seed\": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Mikula-Pietrasik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ijo.2014.2391","article-title":"Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer","volume":"45","author":"Akagawa","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib130","article-title":"Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer","volume":"16","author":"Wang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2024.07.009_bib131","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib132","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/cancers7040872","article-title":"The mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis","volume":"7","author":"Rynne-Vidal","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104442","article-title":"The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis","volume":"115","author":"Demuytere","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib134","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/path.4889","article-title":"Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer","volume":"242","author":"Rynne-Vidal","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40364-021-00305-9","article-title":"Metastasis-associated fibroblasts: an emerging target for metastatic cancer","volume":"9","author":"Wang","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib136","article-title":"Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts","volume":"6","author":"Hamabe-Horiike","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib137","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1172\/JCI62229","article-title":"HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts","volume":"122","author":"Ko","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.07.009_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215737","article-title":"Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression","volume":"540","author":"Walterskirchen","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib139","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","article-title":"Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities","volume":"2","author":"Tanaka","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","article-title":"Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.07.009_bib141","doi-asserted-by":"crossref","first-page":"T155","DOI":"10.1530\/ERC-16-0320","article-title":"Women in cancer thematic review: ovarian cancer-peritoneal cell interactions promote extracellular matrix processing","volume":"23","author":"Ricciardelli","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib142","doi-asserted-by":"crossref","first-page":"304","DOI":"10.21037\/jgo.2019.01.03","article-title":"Circulating TGF-beta1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma","volume":"11","author":"Kimawaha","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib143","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-4598-9-13","article-title":"Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker","volume":"9","author":"Utispan","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib144","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3892\/ol.2017.6250","article-title":"Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis","volume":"14","author":"Thuwajit","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.9738\/INTSURG-D-13-00001.1","article-title":"Mesothelin expression is a prognostic factor in cholangiocellular carcinoma","volume":"98","author":"Nomura","year":"2013","journal-title":"Int Surg"},{"key":"10.1016\/j.ajpath.2024.07.009_bib146","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/cancers15030606","article-title":"Stromal POSTN enhances motility of both cancer and stromal cells and predicts poor survival in colorectal cancer","volume":"15","author":"Ueki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib147","first-page":"821","article-title":"Circulating levels of periostin may help identify patients with more aggressive colorectal cancer","volume":"34","author":"Ben","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib148","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1111\/cas.13712","article-title":"Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer","volume":"109","author":"Dong","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib149","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41389-020-00246-2","article-title":"Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation","volume":"9","author":"Coelho","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ajpath.2024.07.009_bib150","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3390\/ijms21114067","article-title":"From malignant progression to therapeutic targeting: current insights of mesothelin in pancreatic ductal adenocarcinoma","volume":"21","author":"Montemagno","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib151","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1634\/theoncologist.2018-0896","article-title":"Mesothelin expression is a predictive factor for peritoneal recurrence in curatively resected stage III gastric cancer","volume":"24","author":"Shin","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.ajpath.2024.07.009_bib152","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/cancers14122856","article-title":"Role of peritoneal mesothelial cells in the progression of peritoneal metastases","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2015.12.023","article-title":"Endoglin overexpression mediates gastric cancer peritoneal dissemination by inducing mesothelial cell senescence","volume":"51","author":"Miao","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib154","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201501","article-title":"Transforming growth factor-beta1 induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer","volume":"40","author":"Lv","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib155","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.3390\/ijms21114158","article-title":"Reprogramming of mesothelial-mesenchymal transition in chronic peritoneal diseases by estrogen receptor modulation and TGF-beta1 inhibition","volume":"21","author":"Wilson","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib156","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/1873-3468.12722","article-title":"Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier","volume":"591","author":"Deng","year":"2017","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2024.07.009_bib157","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-019-1001-7","article-title":"Exosomes in gastric cancer: roles, mechanisms, and applications","volume":"18","author":"Fu","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111496","article-title":"Mesothelial-to-mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer","volume":"22","author":"Pascual-Anton","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib159","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","article-title":"Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.07.009_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113613","article-title":"Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment","volume":"43","author":"Yonemura","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib161","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yexmp.2014.10.007","article-title":"Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications","volume":"97","author":"Sirica","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib162","first-page":"1147","article-title":"Periostin induces epithelial-to-mesenchymal transition via the integrin alpha5beta1\/TWIST-2 axis in cholangiocarcinoma","volume":"43","author":"Sonongbua","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48485-8","article-title":"Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness","volume":"13","author":"Huang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib164","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3748\/wjg.v21.i9.2605","article-title":"Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis","volume":"21","author":"Liu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2020.11.026","article-title":"Stromal POSTN induced by TGF-beta1 facilitates the migration and invasion of ovarian cancer","volume":"160","author":"Yue","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib166","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59442","article-title":"Collagen-rich omentum is a premetastatic niche for integrin alpha2-mediated peritoneal metastasis","volume":"9","author":"Huang","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2024.07.009_bib167","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2010.07.008","article-title":"Periostin promotes ovarian cancer angiogenesis and metastasis","volume":"119","author":"Zhu","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib168","doi-asserted-by":"crossref","first-page":"89552","DOI":"10.18632\/oncotarget.11533","article-title":"Role of microenvironmental periostin in pancreatic cancer progression","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.07.009_bib169","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-kappaB and TGF-beta2 signaling","volume":"29","author":"Lin","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112090","article-title":"Periostin deficiency reduces PD-1(+) tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2024.07.009_bib171","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41416-023-02516-3","article-title":"Periostin-TGF-beta feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer","volume":"130","author":"Liu","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib172","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-021-02011-8","article-title":"A positive feedback loop between Periostin and TGFbeta1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2alpha activation","volume":"40","author":"Chen","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib173","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7150\/jca.1.141","article-title":"Mesothelin as a potential therapeutic target in human cholangiocarcinoma","volume":"1","author":"Yu","year":"2010","journal-title":"J Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib174","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/biomedicines9040397","article-title":"Mesothelin expression in human tumors: a tissue microarray study on 12,679 tumors","volume":"9","author":"Weidemann","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2024.07.009_bib176","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/MCB.20.8.2902-2906.2000","article-title":"Mesothelin is not required for normal mouse development or reproduction","volume":"20","author":"Bera","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib177","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.07.009_bib178","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2024.07.009_bib179","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.3390\/ijms222212443","article-title":"Host mesothelin expression increases ovarian cancer metastasis in the peritoneal microenvironment","volume":"22","author":"Hilliard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.07.009_bib180","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cancers14061550","article-title":"Mesothelin: an immunotherapeutic target beyond solid tumors","volume":"14","author":"Faust","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1541-7786.MCR-19-0688","article-title":"Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases","volume":"18","author":"Avula","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib182","doi-asserted-by":"crossref","first-page":"F1116","DOI":"10.1152\/ajprenal.00274.2017","article-title":"Thy-1(+\/-) fibroblast subsets in the human peritoneum","volume":"313","author":"Kawka","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib183","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1158\/0008-5472.CAN-23-1542","article-title":"Mesothelin secretion by pancreatic cancer cells co-opts macrophages and promotes metastasis","volume":"84","author":"Luckett","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib184","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.ajpath.2021.08.011","article-title":"Targeting lymphangiogenesis and lymph node metastasis in liver cancer","volume":"191","author":"Roy","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12967-022-03294-x","article-title":"Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives","volume":"20","author":"Zhao","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102170","article-title":"Targeting FGFR inhibition in cholangiocarcinoma","volume":"95","author":"Goyal","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ajpath.2024.07.009_bib187","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.3390\/cancers15153993","article-title":"New era of immune-based therapy in intrahepatic cholangiocarcinoma","volume":"15","author":"Kawamura","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib188","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2024.07.009_bib189","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.32258","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?","volume":"75","author":"Sapisochin","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.07.009_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2024.101951","article-title":"Intrahepatic cholangiocarcinoma biomarkers: towards early detection and personalized pharmacological treatments","volume":"73","author":"Capuozzo","year":"2024","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.ajpath.2024.07.009_bib191","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2020.07.017","article-title":"Intrahepatic cholangiocarcinoma: a single-cell resolution unraveling the complexity of the tumor microenvironment","volume":"73","author":"Fabris","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib192","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cells12060862","article-title":"Revealing the heterogeneity of the tumor ecosystem of cholangiocarcinoma through single-cell transcriptomics","volume":"12","author":"Golino","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.07.009_bib193","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib194","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.18632\/oncotarget.27936","article-title":"Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives","volume":"6","author":"Hanley","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.07.009_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.908156","article-title":"Targeting tumour-associated fibroblasts in cancers","volume":"12","author":"Shah","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2024.07.009_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108231","article-title":"Targeting cancer-associated fibroblasts: challenges, opportunities and future directions","volume":"240","author":"Jenkins","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2024.07.009_bib197","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ajpath.2024.07.009_bib198","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trsl.2024.04.003","article-title":"Targeting the devil: strategies against cancer-associated fibroblasts in colorectal cancer","volume":"270","author":"Chen","year":"2024","journal-title":"Transl Res"},{"key":"10.1016\/j.ajpath.2024.07.009_bib199","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","article-title":"Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy","volume":"43","author":"Guo","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ajpath.2024.07.009_bib200","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3390\/cancers14133132","article-title":"Context matters: response heterogeneity to collagen-targeting approaches in desmoplastic cancers","volume":"14","author":"Fuller","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.07.009_bib201","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-17-2320","article-title":"Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression","volume":"78","author":"Dauer","year":"2018","journal-title":"Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:07:11Z","timestamp":1772327231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":201,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0002944024002797"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.07.009","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}